Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients
- Li-Yang HsuAffiliated withDepartment of Medicine, National University Hospital, Singapore Email author
- , Ying DingAffiliated withDepartment of Medicine, National University Hospital, Singapore
- , Jason PhuaAffiliated withDepartment of Medicine, National University Hospital, Singapore
- , Liang-Piu KohAffiliated withDivision of Hematology, National University Cancer Institute
- , Douglas S ChanAffiliated withDepartment of Laboratory Medicine, National University Hospital
- , Kay-Leong KhooAffiliated withDepartment of Medicine, National University Hospital, Singapore
- , Paul A TambyahAffiliated withDepartment of Medicine, National University Hospital, Singapore
Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality in patients with hematological malignancies in the setting of profound neutropenia and/or hematopoietic stem cell transplantation. Early diagnosis and therapy has been shown to improve outcomes, but reaching a definitive diagnosis quickly can be problematic. Recently, galactomannan testing of bronchoalveolar lavage (BAL) fluid has been investigated as a diagnostic test for IPA, but widespread experience and consensus on optical density (OD) cut-offs remain lacking.
We performed a prospective case-control study to determine an optimal BAL galactomannan OD cutoff for IPA in at-risk patients with hematological diagnoses. Cases were subjects with hematological diagnoses who met established definitions for proven or probable IPA. There were two control groups: subjects with hematological diagnoses who did not meet definitions for proven or probable IPA and subjects with non-hematological diagnoses who had no evidence of aspergillosis. Following bronchoscopy and BAL, galactomannan testing was performed using the Platelia Aspergillus seroassay in accordance with the manufacturer's instructions.
There were 10 cases and 52 controls. Cases had higher BAL fluid galactomannan OD indices (median 4.1, range 1.1-7.7) compared with controls (median 0.3, range 0.1-1.1). ROC analysis demonstrated an optimum OD index cutoff of 1.1, with high specificity (98.1%) and sensitivity (100%) for diagnosing IPA.
Our results also support BAL galactomannan testing as a reasonably safe test with higher sensitivity compared to serum galactomannan testing in at-risk patients with hematological diseases. A higher OD cutoff is necessary to avoid over-diagnosis of IPA, and a standardized method of collection should be established before results can be compared between centers.
- Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
BMC Infectious Diseases
- Online Date
- March 2010
- Online ISSN
- BioMed Central
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Medicine, National University Hospital, Singapore, 5 Lower Kent Ridge Road, 119074, Singapore
- 2. Division of Hematology, National University Cancer Institute, Singapore
- 3. Department of Laboratory Medicine, National University Hospital, Singapore